FDA Recommendations and Safety Concerns With Higher Dose of Tofacitinib in Post-Marketing Study
Tofacitinib dosed at 10mg twice daily was associated with an increased risk of pulmonary embolism and overall mortality in patients with rheumatoid arthritis.